Cardiac review
- Is an ECG part of the pre-treatment assessment?
- Who reviews the result, and what happens if it raises concern?
- Are prior cardiac symptoms or conditions discussed explicitly?
Questions before a decision
Safety & Consent Checklist
A practical set of questions for people researching ibogaine who want to understand the safety processes, emergency planning, and written consent elements a credible program should be prepared to explain.
Information for verification, not a treatment recommendation
A verification mindset
Look for clear answers, not reassurances.
Ibogaine can raise serious practical questions, especially where cardiac risk, medication interactions, withdrawal, and continuity of care are involved. This page is designed to help people researching ibogaine identify the information that should be available before they consider a program.
For broader context on the questions that shape a careful search, the main ibogaine research resource sets out the evidence, safety, legality, and practical issues worth keeping in view. A checklist is not proof that a setting is safe, effective, lawful, or appropriate for any individual.
In the United States, the FDA’s discussion of drug-related heart-rhythm concerns illustrates why medication review and cardiac screening deserve specific, plain-language questions rather than assumptions.
Before any treatment decision
Pre-treatment workup should be specific.
Ask whether the screening process includes a health history, an ECG, and evaluation of electrolytes. Ask how the program reviews medications and supplements, including drugs that may prolong the QT interval or otherwise affect heart rhythm. The clinical significance of QT prolongation is a reason to seek direct, understandable answers about how cardiac concerns are assessed.
Medication review
- Will every prescribed drug, nonprescription drug, and supplement be reviewed?
- How are QT-prolonging medicines identified and handled?
- Who explains possible interaction concerns in writing?
Laboratory context
- Are electrolytes considered before a decision is made?
- What information would prompt postponement or referral elsewhere?
- Can the program explain the limits of its assessment?
During higher-risk windows
Monitoring and emergency planning should not be vague.
-
Ask about continuous ECG monitoring.
Ask whether continuous ECG monitoring is used during periods the program identifies as higher risk, who observes it, and how changes are escalated. Do not accept a general statement that “monitoring is available” in place of an explanation.
-
Ask about resuscitation capability.
Ask what resuscitation equipment is on site, who is trained to use it, and how emergencies are managed. The American Heart Association’s resuscitation guidance underscores that emergency response depends on prepared systems, not simply a stated intention to respond.
-
Ask about transfer and ICU access.
Ask whether there is a formal transfer plan or agreement, what hospital access is realistic from the location, and how a higher level of care would be arranged if needed.
-
Ask about withdrawal and concurrent care.
People may also need to understand how withdrawal, existing treatments, and ongoing medication needs are considered. The wider practical research guidance can help frame questions about evaluating claims and documenting answers.
Questions to bring with you
Ask for the process in writing.
These questions are not instructions for care. They are a way to understand whether a program can describe its screening, monitoring, emergency planning, and follow-up boundaries in terms you can evaluate.
Screening
“What medical information do you review before accepting someone, and what findings would lead you to decline or postpone participation?”
Monitoring
“What monitoring is continuous, during which periods, and who is responsible for interpreting and responding to it?”
Emergency response
“What emergency equipment is present, what transfer process is in place, and what level of hospital or ICU access could be needed?”
Medication and withdrawal
“How do you review medication interactions, withdrawal risks, and the need for coordination with existing care?”
“The consent discussion should make room for questions, alternatives, uncertainty, and the option to say no.”
Written information should support—not replace—a careful conversation. General informed-consent principles are described by the U.S. Department of Health and Human Services, including the importance of understandable information and voluntary decision-making.
Written consent
Plain language is a meaningful signal.
A consent document should not minimize uncertainty or turn serious questions into fine print. It should be available before a pressured decision, and a program should be willing to explain it without evasiveness.
As you compare information, our independent ibogaine research guide may also help keep broader safety and practical questions visible.
What should a written consent document include?
Look for a direct description of known and material risks, including cardiac risk; a statement that efficacy may be uncertain; reasonable alternatives; confidentiality limits; and a clear opportunity to ask questions before deciding.
What might plain-language consent clauses say?
Examples of the kind of language to look for include: “I understand that serious heart-rhythm risks may occur”; “I understand that benefit cannot be guaranteed”; “I understand the alternatives discussed with me”; and “I understand when confidentiality may have legal or safety-related limits.” These are examples of topics to look for, not model clinical or legal documents.
What if a program will not provide documents or answer questions?
That lack of clarity is information in itself. You can pause, seek independent medical or legal guidance, and avoid treating verbal reassurance as a substitute for written, understandable information.
Does this checklist establish that a program is safe?
No. It helps identify questions and missing information. It cannot establish that a particular program, setting, or decision is safe, lawful, appropriate, or effective for you.
Keep the record
Write down what was said—and what was not.
Save consent materials, screening questions, responses about monitoring, and any explanation of emergency transfer arrangements. Clear records can make it easier to compare programs and seek independent advice.